JPMorgan Chase & Co’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-8,978
| Closed | -$41K | – | 5038 |
|
|
2019
Q1 | $41K | Sell |
8,978
-77,374
| -90% | -$353K | ﹤0.01% | 4308 |
|
|
2018
Q4 | $302K | Buy |
86,352
+78,156
| +954% | +$273K | ﹤0.01% | 3617 |
|
|
2018
Q3 | $83K | Buy |
8,196
+996
| +14% | +$10.1K | ﹤0.01% | 4188 |
|
|
2018
Q2 | $53K | Sell |
7,200
-18,424
| -72% | -$136K | ﹤0.01% | 4295 |
|
|
2018
Q1 | $155K | Buy |
25,624
+19,273
| +303% | +$117K | ﹤0.01% | 3799 |
|
|
2017
Q4 | $61K | Sell |
6,351
-51,203
| -89% | -$492K | ﹤0.01% | 4071 |
|
|
2017
Q3 | $508K | Buy |
57,554
+4,231
| +8% | +$37.3K | ﹤0.01% | 3199 |
|
|
2017
Q2 | $674K | Buy |
53,323
+7,629
| +17% | +$96.4K | ﹤0.01% | 3052 |
|
|
2017
Q1 | $480K | Buy |
45,694
+12,561
| +38% | +$132K | ﹤0.01% | 3168 |
|
|
2016
Q4 | $305K | Buy |
33,133
+33,095
| +87,092% | +$305K | ﹤0.01% | 3490 |
|
|
2016
Q3 | $0 | Sell |
38
-50
| -57% | – | ﹤0.01% | 4381 |
|
|
2016
Q2 | $1K | Sell |
88
-119
| -57% | -$1.35K | ﹤0.01% | 4206 |
|
|
2016
Q1 | $3K | Sell |
207
-227,612
| -100% | -$3.3M | ﹤0.01% | 3990 |
|
|
2015
Q4 | $6.52M | Sell |
227,819
-76,098
| -25% | -$2.18M | ﹤0.01% | 1810 |
|
|
2015
Q3 | $8.65M | Buy |
303,917
+68,771
| +29% | +$1.96M | ﹤0.01% | 1664 |
|
|
2015
Q2 | $8.45M | Buy |
235,146
+109,588
| +87% | +$3.94M | ﹤0.01% | 1794 |
|
|
2015
Q1 | $3.65M | Buy |
125,558
+97,010
| +340% | +$2.82M | ﹤0.01% | 2264 |
|
|
2014
Q4 | $601K | Buy |
+28,548
| New | +$601K | ﹤0.01% | 2968 |
|
|
2013
Q4 | – | Sell |
-484,644
| Closed | -$5.65M | – | 3856 |
|
|
2013
Q3 | $5.65M | Sell |
484,644
-674,943
| -58% | -$7.87M | ﹤0.01% | 1958 |
|
|
2013
Q2 | $5.35M | Buy |
+1,159,587
| New | +$5.35M | ﹤0.01% | 1922 |
|